The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...

including inhaled or injectable insulin if they do not use an insulin infusion pump. A diabetes screening usually involves a fasting blood glucose test or a post-glucose challenge test.

Altitude changes during commercial flights may affect the blood glucose levels of people with type 1 diabetes who are treated with insulin pump therapy, according to new research to be presented ...

Fraser Elliott Building, 190 Elizabeth Street, Toronto, ON, Canada M5G 2C4; patricia.trbovich{at}uhn.on.ca Objective Assess the impact of infusion pump technologies (traditional pump vs smart pump vs ...